Shareholder Stefan Murry plans AAOI (AAOI) sale of 17,673 common shares

Rhea-AI Filing Summary

Applied Optoelectronics shareholder Stefan Murry filed a notice to sell 17,673 shares of common stock through Raymond James & Associates on NASDAQ, with an aggregate market value of $883,650. The shares are planned for sale around February 11, 2026, and 68,279,888 shares of common stock were outstanding.

The filing also lists earlier sales of common shares over the prior three months by the same shareholder, including blocks of 4,000 shares on December 10, 2025 and 6,327 shares on February 10, 2026.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	17673	883650.00	68279888	02/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/22/2025	RSU	Issuer			6379	01/22/2025	N/A
Common	10/23/2024	RSU	Issuer			834	10/23/2024	N/A
Common	06/26/2024	RSU	Issuer			2952	06/26/2024	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Stefan Murry 2007 Milford St Houston TX 77098	Common	12/10/2025	4000	126213.00
Stefan Murry 2007 Milford St Houston TX 77098	Common	01/12/2026	3000	101242.00
Stefan Murry 2007 Milford St Houston TX 77098	Common	01/13/2026	934	32690.00
Stefan Murry 2007 Milford St Houston TX 77098	Common	01/15/2026	66	2311.00
Stefan Murry 2007 Milford St Houston TX 77098	Common	02/10/2026	6327	311068.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the AAOI Form 144 filing by Stefan Murry disclose?

The Form 144 discloses that shareholder Stefan Murry intends to sell 17,673 AAOI common shares through Raymond James on NASDAQ. The planned sale has an aggregate market value of $883,650 and is scheduled around February 11, 2026.

How many AAOI shares are planned for sale and on which exchange?

The notice covers the planned sale of 17,673 shares of AAOI common stock. The shares are to be sold through Raymond James & Associates on the NASDAQ exchange, with an indicated aggregate market value of $883,650.

What was the aggregate market value of AAOI shares in this planned Form 144 sale?

The planned sale under Form 144 has an indicated aggregate market value of $883,650 for 17,673 common shares of Applied Optoelectronics. This value reflects the market pricing used in the Form 144 disclosure for the proposed transaction.

How many AAOI shares were outstanding when this Form 144 was prepared?

The Form 144 indicates that 68,279,888 AAOI common shares were outstanding at the time of the notice. This figure provides context for the size of the planned 17,673-share sale relative to the company’s total common shares.

What prior AAOI stock sales by Stefan Murry are listed in the Form 144?

The filing lists several prior AAOI common stock sales by Stefan Murry over three months, including 4,000 shares on December 10, 2025 and 6,327 shares on February 10, 2026, along with other smaller transactions and disclosed gross proceeds.

How were the AAOI shares to be sold originally acquired according to the filing?

The Form 144 shows that the common shares planned for sale were acquired through RSU grants from the issuer on dates including June 26, 2024, October 23, 2024, and January 22, 2025, with the nature of payment noted as N/A.